基于Keap1/Nrf2/HO-1信号通路探讨毛兰素对前列腺癌细胞铁死亡的影响OA
Effects of Erianin on Ferroptosis in Prostate Cancer Cells via the Keap1/Nrf2/HO-1 Signaling Pathway
目的 探讨毛兰素是否通过调控Keap1/Nrf2/HO-1信号通路,进而影响前列腺癌细胞的铁死亡进程.方法 培养DU145和PC-3前列腺癌细胞系.CCK-8、集落形成测定、细胞侵袭实验和流式细胞术检测细胞活力、迁移、侵袭和凋亡.使用ROS特异性探针DCFH-DA分析细胞内ROS含量,检测丙二醛(malondialdehyde,MDA)和谷胱甘肽(glutathione,GSH)含量,蛋白质印迹法测量细胞中转移性表型标志物的表达(vimentin、N-cadherin、slug、snail 和 MMP-9)表达、铁死亡阴性调控蛋白(GPX4、CHAC2、SLC40A1、SLC7A11和glutaminase)的表达和Keap1/Nrf2/HO-1信号通路表达.结果 与对照组比较,毛兰素显著降低前列腺癌细胞(DU145、PC-3)活力,抑制其增殖、迁移及侵袭能力(P<0.05);毛兰素可下调间充质标志物vimentin、N-cadherin、slug、snail和MMP-9并上调上皮标志物E-cadherin来抑制前列腺癌细胞的迁移(P<0.05),ROS积累、谷胱甘肽消耗和脂质过氧化显著增加(P<0.05),毛兰素诱导的前列腺癌细胞死亡可以通过与ROS抑制剂n-乙酰-l-半胱氨酸(NAC)和GSH共处理来挽救.毛兰素处理后,Phen Green SK(检测细胞内游离Fe2+)阳性细胞比例显著下降(P<0.05).透射电子显微镜(transmission electron microscope,TEM)结果发现,经毛兰素处理的前列腺癌细胞出现线粒体基质凝结和嵴增大.毛兰素处理后,铁死亡阴性调控蛋白GPX4、CHAC2、SLC40A1、SLC7A11和glutaminase的表达明显降低(P<0.05),与铁死亡抑制剂利蒲他汀-1(Lip-1)或铁他汀-1(Fer-1)联合治疗,可以阻断毛兰素诱导的前列腺癌细胞死亡,毛兰素提高了 Keap1蛋白表达(P<0.05),而细胞中的Nrf2,HO-1和NQO1蛋白表达降低(P<0.05).CPUY192018可提高前列腺癌细胞铁死亡,表明毛兰素靶向Keap1/Nrf2/HO-1信号通路诱导细胞铁死亡.结论 毛兰素靶向Keap1/Nrf2/HO-1信号通路诱导细胞死亡和抑制前列腺癌细胞转移.
Objectives To investigate whether erianin induces ferroptosis in prostate cancer cells by regula-ting the Keap1/Nrf2/HO-1 signaling pathway.Methods Human prostate cancer cell lines DU145 and PC-3 were cultured.Cell viability was detected by CCK-8 assay,cell proliferation by colony formation assay,cell invasion by Transwell assay,and cell apoptosis by flow cytometry.Intracellular reactive oxygen species(ROS)content was analyzed using the ROS-specific probe DCFH-DA,and the levels of malondialdehyde(MDA)and glutathione(GSH)were determined.Western blot was used to detect the expression of metastatic phenotypic markers(vimentin,N-cadherin,slug,snail,andMMP-9),ferroptosis-negative regulatory proteins(GPX4,CHAC2,SLC40A1,SLC7A11,and glutaminase),and proteins related to the Keap1/Nrf2/HO-1 signaling pathway.Results Compared with the control group,erianin significantly reduced the viability of prostate cancer cells(DU 145,PC-3)and inhibited their proliferation,migration,and invasion abilities(P<0.05).Erianin inhibited the migration of prostate cancer cells by downregulating the mesenchymal markers(vimentin,N-cadherin,slug,snail,and MMP-9)and upregulating the epithelial marker E-cadherin.ROS accumulation,GSH depletion,and lipid peroxidation were significantly increased(P<0.05).Erianin-induced prostate cancer cell death could be rescued by co-treatment with the ROS inhibitor N-acetyl-L-cysteine(NAC)and glutathione(GSH).After erianin treatment,the proportion of Phen Green SK-positive cells(detecting intracellular free Fe2+)was significantly decreased(P<0.05).Transmission electron microscopy(TEM)revealed mitochondrial matrix condensation and cristae enlargement in erianin-treated prostate cancer cells.Additionally,erianin treatment significantly downregulated the expression of ferroptosis-negative regulatory proteins(GPX4,CHAC2,SLC40A1,SLC7A11,and glutaminase)(P<0.05).Co-treatment with ferroptosis inhibitors(Liproxstatin-1,Lip-1;or Ferrostatin-1,Fer-1)blocked erianin-induced prostate cancer cell death.Erianin increased Keap1 protein expression while decreasing the expression of Nrf2,HO-1,and NQO1 proteins in cells(P<0.05).CPUY192018 enhanced ferroptosis in prostate cancer cells,indicating that erianin induces ferroptosis through targeting the Keap1/Nrf2/HO-1 signaling pathway.Conclusion Erianin induces cell death and suppresses prostate cancer cell migration by targeting the Keap1/Nrf2/HO-1 signaling pathway.
赵海英;刘建荣;向阳
中国人民解放军联勤保障部队第961医院泌尿外科,黑龙江 齐齐哈尔 161006中国人民解放军联勤保障部队第961医院泌尿外科,黑龙江 齐齐哈尔 161006齐齐哈尔市第一医院泌尿外科,黑龙江 齐齐哈尔 161005
医药卫生
毛兰素Keap1/Nrf2/HO-1前列腺癌铁死亡
ErianinKeap1/Nrf2/HO-1 Signaling pathwayProstate cancerFerroptosis
《昆明医科大学学报》 2026 (8)
38-47,10
黑龙江省卫生健康委员会科研基金(H186150198)
评论